Okomera

Okomera is a biotech company that develops and offers an automated 3D organoid screening technology. This technology integrates standard assays on a chip, such as CRISPR and T-cell assays, to accelerate drug discovery, support target validation, and improve the predictability of preclinical studies, ultimately advancing personalized cancer treatments.